- Home
- KZIA vs DCGO Comparison
KZIA vs DCGO Comparison
Compare KZIA & DCGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KZIA | DCGO |
|---|---|---|
| Founded | 1994 | 2015 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Managed Health Care |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.8M | 67.0M |
| IPO Year | 2002 | 2020 |
Fundamental Metrics
Financial Performance| Metric | KZIA | DCGO |
|---|---|---|
| Price | $5.91 | $0.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $17.67 | $3.33 |
| AVG Volume (30 Days) | 217.9K | ★ 797.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 200.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $616,555,132.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.64 | $0.66 |
| 52 Week High | $17.40 | $4.52 |
Technical Indicators
Market Signals| Indicator | KZIA | DCGO |
|---|---|---|
| Relative Strength Index (RSI) | 45.81 | 44.04 |
| Support Level | $5.45 | $0.66 |
| Resistance Level | $8.05 | $0.95 |
| Average True Range (ATR) | 0.58 | 0.07 |
| MACD | 0.13 | 0.01 |
| Stochastic Oscillator | 61.68 | 48.33 |
Price Performance
Historical ComparisonAbout KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.
About DCGO DocGo Inc.
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has three reporting segments: Mobile Health Services, Transportation Services, and Corporate. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.